Stock Screener App

無料 -

インストール

Drug Manufacturers - Specialty & Generic

0.00

100.00% -0.25

Eagle Pharmaceuticals Inc (EGRX)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Eagle Pharmaceuticals Inc (EGRX) 最新ニュース

Eagle Point Announces Strong Year of Performance with 2025 Year-End Review - Yahoo Finance

American Eagle to Participate in PDAC 2026 and Ore Day VIP Investor Lunch - Yahoo Finance

EDGAR Filing Documents for 0001104659-19-033601 - SEC.gov

Eagle Health Investments LP Sells 22,400 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Eagle Health Investments LP Sells 84,600 Shares of Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Wall Street Bullish on Agnico Eagle Mines (AEM) After FQ4 Results - Yahoo Finance

Is Trending Stock American Eagle Outfitters, Inc. (AEO) a Buy Now? - Yahoo Finance

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation - Eagle-Tribune

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development - eagletribune.com

Deal Watch: Kuva Labs To Go Public Via Merger With Licensing Partner Lisata - Citeline News & Insights

Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Agnico Eagle Mines Limited $AEM Shares Acquired by Campbell & CO Investment Adviser LLC - Defense World

Eagle Pharmaceuticals Announces Divestiture Of Barhemsys - TradingView

Eagle Pharmaceuticals Announces Divestiture of Barhemsys - The Manila Times

Only FDA-approved post-surgery nausea drug shifts to new owner - Stock Titan

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound - Eagle-Tribune

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies - Yahoo Finance

Top Research Reports for JPMorgan Chase, RTX & Applied Materials - TradingView

Aadi Bioscience (NASDAQ:AADI) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Survey - Defense World

Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Crosses Above Fifty Day Moving Average – Here’s What Happened - Defense World

Eagle Point Credit Company Inc. Announces Full Redemption of the 8.00% Series F Term Preferred Stock Due 2029 - Yahoo Finance

Pemetrexed Market Industry Forecast 2025-2032 Highlights - openPR.com

HALPER SADEH LLC ENCOURAGES EAGLE PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve

Talon Metals to Acquire Lundin Mining's Eagle Mine and Humboldt Mill Operations, Creating a Multi-Asset U.S. Nickel-Copper Company - Yahoo Finance

Amphastar Announces FDA Approval for Teriparatide Injection - Eagle-Tribune

Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome - Eagle-Tribune

DHIL Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Diamond Hill Investment Group, Inc. is Fair to Shareholders - Business Wire

Critical Review: NexImmune (NASDAQ:NEXI) and Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World

Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal

Reviewing Eagle Pharmaceuticals (NASDAQ:EGRX) and Bio-Path (NASDAQ:BPTH) - Defense World

EB Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Eventbrite, Inc. is Fair to Shareholders - Business Wire

Eagle Pharmaceuticals (NASDAQ:EGRX) Share Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday - Benzinga

Galectin Therapeutics: NAVIGATE Data Validates The Fibrosis Thesis - Seeking Alpha

Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3 - Insider Monkey

ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States - NEWS CHANNEL NEBRASKA- Northeast

Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Passes Below 200 Day Moving Average – What’s Next? - Defense World

Vanda Pharmaceuticals: Commercial Execution Meets Pipeline Optionality (NASDAQ:VNDA) - Seeking Alpha

Telomir Pharmaceuticals director Craig Eagle resigns from board - Investing.com

ACA Pharma Announces 2026 China NPP Group Procurement Priority List for Orphan and Clinically Urgent Drugs - PRWeb

Antiemetics Drugs Market Size Worth USD 30.63 Billion by 2034 - BioSpace

U.S. Vasopressin Market Poised for Transformation with - openPR.com

Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan - The Manila Times

Eagle Pharma (OTCMKTS: EGRX) extends stockholder rights plan to 2026; $20 exercise - Stock Titan

Giant Eagle opens new pharmacy in Mt. Washington, filling gap left by Rite Aid - WTAE

Total debt per share of EAGLE PHARMACEUTICALS INC – OTC:EGRX - TradingView

Revenue per share of Eagle Pharmaceuticals, Inc. – LS:A1XEDS - TradingView

Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East - PR Newswire

Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Halper Sadeh LLC Encourages Acadia Pharmaceuticals Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders - The Manila Times

Eagle Pharmaceuticals (OTCMKTS: EGRX) posts 82% quorum; directors elected, BDO ratified - Stock Titan

Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements - The Manila Times

Unaudited Q2 2025 financials available — Eagle Pharmaceuticals posts three- and six-month statements - Stock Titan

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements - The Manila Times

Q1 2025 Unaudited Financials — Eagle Pharmaceuticals posts statements and investor materials available now - Stock Titan

McCarter & English Launches Wave of Pharma Patent Infringement Suits in Delaware - Law.com

EGRX STOCKHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Eagle Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

ELAN

$23.66

3.11%

RDY

$14.22

0.45%

RGC

$24.11

4.30%

NBIX

$130.88

1.99%

VTRS

$14.46

1.70%

UTHR

$483.11

1.29%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く